You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Blood Sugar Articles
Popular Blood Sugar Articles
Highly Recommended Blood Sugar Articles
Send a link to this page to your friends and colleagues.
For the majority of Americans who suffer from type 2 diabetes, a new sulfonylurea drug, Amaryl (glimepiride tablets) may be an exciting option. Recently approved by the FDA, is the only drug of its kind indicated for use either on its own or with insulin, although the combined use may increase the potential for hypoglycemia. Amaryl binds to a different insulin receptor site than other sulfonylureas to provide sustained glucose control.
Doctors will prescribe doses of Amaryl at one to four milligrams daily. According to the manufacturer, Hoechst Marion Roussel, studies have shown that the drug is significantly absorbed from the GI tract within one hour of ingestion. Amaryl performed well in clinical studies among a variety of patients, including obese and hypersensitive subjects. Hoechst Marion Roussel claims Amaryl provides faster glucose stabilization than glipizide and safer stabilization than glyburide.
It is important for people taking Amaryl to follow a regimen of diet and exercise. According to company literature, "Loss of blood glucose control on diet and exercise alone may be transient, thus requiring only short-term administration of Amaryl." Though all sulfonylurea drugs can cause low blood sugar, doctors found Amaryl to be the least likely to cause hypoglycemia.
People who should not take the drug are those with a known hypersensitivity to Amaryl, or those with ketoacidosis.
Amaryl is one of the first products to receive FDA clearance for the newly formed Hoechst Marion Roussel, the global pharmaceutical division of Hoechst AG in Frankfurt, Germany.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.